Atlas FDA

KAMRA INLAY

FDA premarket approval P120023/S001 · decided 2016-05-12

Approval details

PMA number
P120023
Supplement
S001
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol - OSB
Trade name
KAMRA INLAY
Generic name
Implant, corneal, refractive
Applicant
Corneagen
Date received
2015-05-18
Decision date
2016-05-12
Days to decision
360 days
Decision code
APPR
Product code
LQE
Advisory committee
Ophthalmic
Expedited review
No
Location
Seattle, WA
Statement
Approval of the post approval study protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.